• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的神经传递系统。

Neurotransmission systems in Parkinson's disease.

作者信息

Sanjari Moghaddam Hossein, Zare-Shahabadi Ameneh, Rahmani Farzaneh, Rezaei Nima

出版信息

Rev Neurosci. 2017 Jul 26;28(5):509-536. doi: 10.1515/revneuro-2016-0068.

DOI:10.1515/revneuro-2016-0068
PMID:28328536
Abstract

Parkinson's disease (PD) is histologically characterized by the accumulation of α-synuclein particles, known as Lewy bodies. The second most common neurodegenerative disorder, PD is widely known because of the typical motor manifestations of active tremor, rigidity, and postural instability, while several prodromal non-motor symptoms including REM sleep behavior disorders, depression, autonomic disturbances, and cognitive decline are being more extensively recognized. Motor symptoms most commonly arise from synucleinopathy of nigrostriatal pathway. Glutamatergic, γ-aminobutyric acid (GABA)ergic, cholinergic, serotoninergic, and endocannabinoid neurotransmission systems are not spared from the global cerebral neurodegenerative assault. Wide intrabasal and extrabasal of the basal ganglia provide enough justification to evaluate network circuits disturbance of these neurotransmission systems in PD. In this comprehensive review, English literature in PubMed, Science direct, EMBASE, and Web of Science databases were perused. Characteristics of dopaminergic and non-dopaminergic systems, disturbance of these neurotransmitter systems in the pathophysiology of PD, and their treatment applications are discussed.

摘要

帕金森病(PD)在组织学上的特征是α-突触核蛋白颗粒的积累,即路易小体。作为第二常见的神经退行性疾病,PD广为人知是因为其典型的运动表现,如主动震颤、僵硬和姿势不稳,而包括快速眼动睡眠行为障碍、抑郁、自主神经功能紊乱和认知衰退在内的几种前驱非运动症状也得到了更广泛的认识。运动症状最常见于黑质纹状体通路的突触核蛋白病。谷氨酸能、γ-氨基丁酸(GABA)能、胆碱能、5-羟色胺能和内源性大麻素神经传递系统也未能幸免于全球脑性神经退行性攻击。基底神经节广泛的基底内和基底外区域为评估PD中这些神经传递系统的网络回路紊乱提供了充分的依据。在这篇综述中,查阅了PubMed、Science direct、EMBASE和Web of Science数据库中的英文文献。讨论了多巴胺能和非多巴胺能系统的特征、这些神经递质系统在PD病理生理学中的紊乱及其治疗应用。

相似文献

1
Neurotransmission systems in Parkinson's disease.帕金森病中的神经传递系统。
Rev Neurosci. 2017 Jul 26;28(5):509-536. doi: 10.1515/revneuro-2016-0068.
2
Multifactorial sleep disturbance in Parkinson's disease.帕金森病中的多因素睡眠障碍
Sleep Med. 2017 Jul;35:41-48. doi: 10.1016/j.sleep.2017.03.026. Epub 2017 Apr 25.
3
The pathomechanisms underlying Parkinson's disease.帕金森病的发病机制。
Expert Rev Neurother. 2014 Feb;14(2):199-215. doi: 10.1586/14737175.2014.877842.
4
TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease.TGF-β/Smad3 信号通路调节 GABA 神经传递:在帕金森病中的意义。
Int J Mol Sci. 2020 Jan 16;21(2):590. doi: 10.3390/ijms21020590.
5
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems.帕金森病药物治疗的进展:针对神经递质系统。
Trends Neurosci. 2013 Sep;36(9):543-54. doi: 10.1016/j.tins.2013.06.003. Epub 2013 Jul 19.
6
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night.睡眠障碍导致帕金森病还是相反:良好的 GABA 带来美好的夜晚。
CNS Neurosci Ther. 2024 Mar;30(3):e14521. doi: 10.1111/cns.14521.
7
[Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].[选择性刺激和损伤大鼠脑核作为研究人类睡眠病理机制的模型]
Glas Srp Akad Nauka Med. 2011(51):85-97.
8
Non-motor extranigral signs and symptoms in Parkinson's disease.帕金森病的非运动性外显体征和症状。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12. doi: 10.1016/S1353-8020(09)70770-9.
9
New pharmacological options for treating advanced Parkinson's disease.治疗晚期帕金森病的新药理学选择。
Clin Ther. 2013 Oct;35(10):1640-52. doi: 10.1016/j.clinthera.2013.08.011. Epub 2013 Sep 5.
10
[Rapid-eye-movement sleep disorders in Parkinson's disease].[帕金森病中的快速眼动睡眠障碍]
Rev Neurol (Paris). 2002 Feb;158(2):135-52.

引用本文的文献

1
The function of chloride channels in digestive system disease (Review).氯离子通道在消化系统疾病中的作用(综述)
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5540. Epub 2025 May 2.
2
Demographic and Clinical Characteristics in Different Motor Subtypes of Parkinson's Disease: How Well Do the Findings Fit Within the Framework of Existing Hypotheses?帕金森病不同运动亚型的人口统计学和临床特征:这些发现与现有假说框架的契合程度如何?
Neurol Int. 2025 Mar 27;17(4):51. doi: 10.3390/neurolint17040051.
3
Clinical efficacy and potential mechanisms of acupuncture for Parkinson's disease: the role of GABAergic signaling.
针灸治疗帕金森病的临床疗效及潜在机制:GABA能信号传导的作用
Front Neurosci. 2025 Feb 19;19:1525486. doi: 10.3389/fnins.2025.1525486. eCollection 2025.
4
Effects of a Rosiridin against Rotenone-induced Rats' Model of Parkinson's Disease: In-vivo Study and in silico Molecular Modeling.罗西里定对鱼藤酮诱导的大鼠帕金森病模型的影响:体内研究与计算机分子模拟
Curr Neuropharmacol. 2025 Feb 13;23(9):1095-118. doi: 10.2174/011570159X349553250126050134.
5
Network pharmacology combined with experimental validation show that apigenin as the active ingredient of Campsis grandiflora flower against Parkinson's disease by inhibiting the PI3K/AKT/NF-κB pathway.网络药理学结合实验验证表明,凌霄花的有效成分芹菜素通过抑制 PI3K/AKT/NF-κB 通路来治疗帕金森病。
PLoS One. 2024 Oct 9;19(10):e0311824. doi: 10.1371/journal.pone.0311824. eCollection 2024.
6
Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain.血清/糖皮质激素调节激酶 1(SGK1)在神经疾病中的作用:双刃剑。
Exp Neurol. 2024 Dec;382:114973. doi: 10.1016/j.expneurol.2024.114973. Epub 2024 Sep 24.
7
Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson's Disease.脑内氨茶碱给药对帕金森病动物模型的僵直和步态的影响。
Int J Mol Sci. 2024 May 10;25(10):5191. doi: 10.3390/ijms25105191.
8
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review.L-肉碱治疗精神和神经表现的系统评价
Nutrients. 2024 Apr 20;16(8):1232. doi: 10.3390/nu16081232.
9
Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease.在一个分级剂量 6-OHDA 帕金森病早期小鼠模型中观察到的行为、神经和超微结构改变。
Sci Rep. 2023 Nov 9;13(1):19478. doi: 10.1038/s41598-023-46576-0.
10
Alterations in neurotransmitter co-release in Parkinson's disease.帕金森病中神经递质共释放的改变。
Exp Neurol. 2023 Dec;370:114562. doi: 10.1016/j.expneurol.2023.114562. Epub 2023 Oct 5.